Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Dec 5;143(11):e97.
doi: 10.1093/brain/awaa306.

Aggressive multiple sclerosis: a matter of measurement and timing

Affiliations
Comment

Aggressive multiple sclerosis: a matter of measurement and timing

David Ellenberger et al. Brain. .
No abstract available

PubMed Disclaimer

Figures

Figure 1
Figure 1
Aggressive multiple sclerosis according to various definitions. (A) Proportions of aggressive multiple sclerosis (MS) patients over time according to different definitions. In this interval-censored Cox model, the rising proportions of patients in the GMSR classified as aggressive multiple sclerosis according to the definitions of Freedman and Rush (2016), Díaz et al. (2019), Spelman et al. (2020), Gholipour et al. (2011), Menon et al. (2017), Tintore et al. (2019) and Malpas et al. (2020) (10 years) were presented depending on the disease duration from symptom onset. Additionally, the proportion of early retired patients in the first 5 years is given. (B) Venn diagram showing overlapping proportions of aggressive multiple sclerosis patients according to various definitions in the first 5 years of the disease (n =752). Comparison of aggressive multiple sclerosis patients according to Freedman and Rush (2016) (F) Díaz et al. (2019), Gholipour et al. (2011) (G) Menon et al. (2017), Spelman et al. (2020) (S) and the early retired (ER) patients with aggressive multiple sclerosis.

Comment in

Comment on

  • Early clinical markers of aggressive multiple sclerosis.
    Malpas CB, Manouchehrinia A, Sharmin S, Roos I, Horakova D, Havrdova EK, Trojano M, Izquierdo G, Eichau S, Bergamaschi R, Sola P, Ferraro D, Lugaresi A, Prat A, Girard M, Duquette P, Grammond P, Grand'Maison F, Ozakbas S, Van Pesch V, Granella F, Hupperts R, Pucci E, Boz C, Sidhom Y, Gouider R, Spitaleri D, Soysal A, Petersen T, Verheul F, Karabudak R, Turkoglu R, Ramo-Tello C, Terzi M, Cristiano E, Slee M, McCombe P, Macdonell R, Fragoso Y, Olascoaga J, Altintas A, Olsson T, Butzkueven H, Hillert J, Kalincik T. Malpas CB, et al. Brain. 2020 May 1;143(5):1400-1413. doi: 10.1093/brain/awaa081. Brain. 2020. PMID: 32386427

References

    1. Díaz C, Zarco LA, Rivera DM.. Highly active multiple sclerosis: an update. Mult Scler Relat Disord 2019; 30: 215–24. - PubMed
    1. Freedman MS, Rush CA.. Severe, highly active, or aggressive multiple sclerosis. Continuum (Minneap Minn) 2016; 22: 761–84. - PubMed
    1. Gholipour T, Healy B, Baruch NF, Weiner HL, Chitnis T.. Demographic and clinical characteristics of malignant multiple sclerosis. Neurology 2011; 76: 1996–2001. - PubMed
    1. Iacobaeus E, Arrambide G, Pia Amato M, Derfuss T, Vukusic S, Hemmer B, et al.Aggressive multiple sclerosis (1): towards a definition of the phenotype. Mult Scler 2020; 12: 1352458520925369. - PMC - PubMed
    1. Malpas CB, Manouchehrinia A, Sharmin S, Roos I, Horakova D, Havrdova EK, et al.Early clinical markers of aggressive multiple sclerosis. Brain J Neurol 2020; 143: 1400–13. - PubMed